CDKN2A and brain neoplasm: By exploiting a nicely constructed Cre/lox animal model Robinson and colleagues were able to demonstrate that the combination of BRAF mutation with Akt activation or Ink4a/ARF loss is required to generate brain tumors with high-grade appearance [4].